Breakthrough fungemia appearing during empiric therapy with amphotericin B.
Krcméry
V
V
University of Trnava, Department of Medicine, Slovak Republic.
Spanik
S
S
Kunova
A
A
Trupl
J
J
D000666:Amphotericin B / Q000494:pharmacology* / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002176:Candida albicans / Q000302:isolation & purification; D003454:Cryptococcus / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D005260:Female; D016469:Fungemia / Q000209:etiology*; D005670:Fusarium / Q000302:isolation & purification; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications; D012307:Risk Factors
D000935:Antifungal Agents; D000666:Amphotericin B